Study to Evaluate the Long Term Safety & Efficacy of DWP16001 Compared to

See also
Status	Clinical Trial	Phase
Completed	`NCT01373814` - Nutritional Therapy for Diabetic Cardiomyopathy
Recruiting	`NCT05469659` - Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)	Phase 2
Recruiting	`NCT04682795` - Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM	N/A
Recruiting	`NCT06350890` - Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes	Phase 3
Completed	`NCT04634500` - The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.	Phase 3
Recruiting	`NCT03789695` - RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD	Phase 4
Completed	`NCT04632862` - The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.	Phase 3
Completed	`NCT04688359` - Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM	N/A
Completed	`NCT05983289` - Single Escalating Dose Study Of HSK7653 In Healthy Subjects	Phase 1
Recruiting	`NCT04272359` - Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
Not yet recruiting	`NCT06094491` - Virtual Diabetes Group Visits Across Health Systems	N/A
Completed	`NCT03467932` - A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus	Phase 2
Completed	`NCT05376969` - Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin	Phase 3
Completed	`NCT05279911` - Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion	N/A
Active, not recruiting	`NCT03257449` - Effect of Viscous Soluble Fibres on Body Weight	N/A
Terminated	`NCT04754334` - A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus	Phase 3
Not yet recruiting	`NCT06293417` - To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Not yet recruiting	`NCT03658031` - Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction	Phase 3
Terminated	`NCT03067480` - Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients	N/A
Completed	`NCT03155087` - PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy	N/A

NCT number	NCT05376930
Study type	Interventional
Source	Daewoong Pharmaceutical Co. LTD.
Contact
Status	Completed
Phase	Phase 3
Start date	September 16, 2021
Completion date	May 31, 2022

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms